Sunshine Subsidiary Nora Pharma Secures Canadian Approval For Neulasta Biosimilar
The Approval Marks A Further Step In Reaching Profitability
Executive Summary
The approval brings another biosimilar to Amgen’s Neulasta, stepping up competition in an already heated market that has seen major approvals in the past year.